Actinobacteria in natural products research: Progress and prospects

Microbiol Res. 2021 May:246:126708. doi: 10.1016/j.micres.2021.126708. Epub 2021 Jan 22.

Abstract

Actinobacteria are well-recognised biosynthetic factories that produce an extensive spectrum of secondary metabolites. Recent genomic insights seem to impact the exploitation of these metabolically versatile bacteria in several aspects. Notably, from the isolation of novel taxa to the discovery of new compounds, different approaches evolve at a steady pace. Here, we systematically discuss the enduring importance of Actinobacteria in the field of drug discovery, the current focus of isolation efforts targeting bioactive Actinobacteria from diverse sources, recent discoveries of novel compounds with different bioactivities, and the relative employment of different strategies in the search for novel compounds. Ultimately, we highlight notable progress that will have profound impacts on future quests for secondary metabolites of Actinobacteria.

Keywords: Actinobacteria; Actinobacterial biology, Antibiotics; Genome mining; Natural products; Novel compounds; Streptomyces.

Publication types

  • Review

MeSH terms

  • Actinobacteria / genetics*
  • Actinobacteria / isolation & purification*
  • Anti-Infective Agents / isolation & purification
  • Antineoplastic Agents / isolation & purification
  • Biological Products / isolation & purification*
  • Drug Discovery / trends*
  • Genome, Bacterial
  • Immunosuppressive Agents / isolation & purification

Substances

  • Anti-Infective Agents
  • Antineoplastic Agents
  • Biological Products
  • Immunosuppressive Agents